NL-OMON20178招募中不适用
Implementation of pharmacokinetic (PK)-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease and low VWF
Erasmus University Medical Center - Sophia Children's Hospital, University Medical Center Rotterdam0 个研究点目标入组 123 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 123
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •No minimum or maximum age at inclusion date;
- •-Hemorrhagic symptoms or a family history of von Willebrand disease or low VWF with historically lowest levels of VWF:Ag and/or VWF:Act and/or VWF:Cb <0.60 IU/ml and/or FVIII <0.40 IU/ml (only in type 2N);
排除标准
- •-Any other known hemostatic abnormalities;
- •-Acquired VWD;
研究者
相似试验
进行中（未招募）
1 期
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000004850HemophiliaEUCTR2018-003869-33-NLErasmus University Medical Center50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patientsNL-OMON27791Erasmus Medical Center, Sophia Children's Hospital50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.hemophiliaNL-OMON55874Erasmus MC, Universitair Medisch Centrum Rotterdam50
招募中
不适用
Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand diseaseNL-OMON54546Erasmus MC, Universitair Medisch Centrum Rotterdam160
进行中（未招募）
1 期
Effects of pharmacokinetic models in dosing of DDAVP and/or von Willebrand factor-containing concentrates in patients with von Willebrand diseaseVon Willebrand diseaseMedDRA version: 20.0Level: LLTClassification code 10055168Term: Von Willebrand's factor deficiencySystem Organ Class: 100000004850EUCTR2018-001631-46-NLErasmus University Medical Center120